<?xml version="1.0" encoding="UTF-8"?>
<p id="p0245">The increased risk of psychosis in people exposed to a virus during an epi- or pandemic is more compelling. Between 0.9% and 4% of people exposed develop psychosis or psychotic symptoms (hallucinations and/or delusions). This is in contrast to a median incident rate of 15.2 in 100,000 (
 <xref rid="bb0125" ref-type="bibr">McGrath et al., 2004</xref>). In some cases the psychosis seemed to be associated with treatment with steroids used to treat the infection, e.g. 
 <xref rid="bb0120" ref-type="bibr">Mak et al. (2009)</xref>. Treatment with low doses of antipsychotic medication - notably aripiprazole - seems to have been effective in patients with an emerging infectious disease and those associated with psychosocial stress associated with an emerging infectious disease.
</p>
